SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.

Autor: Zheng, Xiaobin1 (AUTHOR), Lin, Jing2,3 (AUTHOR), Xiong, Jiani2,3 (AUTHOR), Guan, Yanfang4 (AUTHOR), Lan, Bin2 (AUTHOR), Li, Yi1 (AUTHOR), Gao, Xuan4 (AUTHOR), Fei, Zhaodong1,3 (AUTHOR), Chen, Lisha1,3 (AUTHOR), Chen, Lizhu2,3 (AUTHOR), Chen, Ling2,3 (AUTHOR), Chen, Gang3,5 (AUTHOR), Guo, Zengqing2,3 (AUTHOR), Yi, Xin4 (AUTHOR), Cao, Weiguo6 (AUTHOR), Ai, Xinghao7 (AUTHOR), Zhou, Chengzhi8 (AUTHOR), Li, Xiaofeng9 (AUTHOR), Zhao, Jun10 (AUTHOR), Yan, Xiangtao11 (AUTHOR)
Zdroj: BMC Cancer. 7/21/2023, Vol. 23 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje